Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride voltage-gated channel 7 (CLCN7) is an ion transporter that enables the exchange of chloride ions with protons across organellar membranes, notably in lysosomes and osteoclasts. Its function is crucial for acidification in osteoclasts during bone resorption, regulating pH to allow the breakdown of bone tissue. Mutations disrupt channel function, causing improper bone remodeling and resulting in osteopetrosis, characterized by increased bone density and abnormal bone structure. CLCN7 also impacts lysosomal function and pigment production, and genetic variants are associated with lysosomal storage disease and hypopigmentation.
Inhibition of chloride/proton transport function, which could alter pH regulation relevant in pathologies such as osteopetrosis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride voltage-gated channel 7 (CLCN7).